$105.840
-5.408 (-5.11%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
DNTH Prediction & Forecast by Similar Chart Analysis
Alphio's DNTH stock price prediction model matches the current Dianthus Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $105.13 (-0.67%). The 1-week path is $104.55 (-1.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Dianthus Therapeutics Inc Stock?
Dianthus Therapeutics Inc is currently a hold. The stock is priced at $105.84, which is below the average analyst price target of $125, indicating potential upside. However, the RSI is at 32.032, suggesting it is oversold, and the company reported a significant revenue decline of 99.6% year-over-year, which raises concerns about its market demand and profitability. The main risk is the ongoing net income losses, with a reported net income of -$50,215,000 in Q2 2026, which could impact future financing efforts.
DNTH stock price ended at $105.84 on Friday, after losing -5.11%
Dianthus Therapeutics Inc (DNTH) last closed at $105.84, losing -5.11%. These facts feed the 1-day and 1-week DNTH price prediction above.
Forecast Drivers
Dianthus Therapeutics Inc (DNTH) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches DNTH, ranked by similarity.
Seasonality analysis for DNTH
Historically the probability of a positive August return for DNTH is 79.37%. September offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for DNTH
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $26.97 | $28.75 | $29.65 | -72.84% |
| Sep 2026 | $19.57 | $24.64 | $36.59 | -76.72% |
| Oct 2026 | $23.41 | $28.86 | $33.51 | -72.74% |
| Nov 2026 | $24.47 | $36.24 | $46.67 | -65.76% |
| Dec 2026 | $17.85 | $24.64 | $27.54 | -76.72% |
In 2026, Dianthus Therapeutics Inc (DNTH) is projected to range from $17.85 to $46.67.
Dianthus Therapeutics Inc 2026 monthly forecast
In Aug 2026, Dianthus Therapeutics Inc is projected to average $28.75, with a low of $26.97 and high of $29.65.
In Sep 2026, Dianthus Therapeutics Inc is projected to average $24.64, with a low of $19.57 and high of $36.59.
In Oct 2026, Dianthus Therapeutics Inc is projected to average $28.86, with a low of $23.41 and high of $33.51.
In Nov 2026, Dianthus Therapeutics Inc is projected to average $36.24, with a low of $24.47 and high of $46.67.
In Dec 2026, Dianthus Therapeutics Inc is projected to average $24.64, with a low of $17.85 and high of $27.54.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。